Quarterly results
consolidated · as filed with NSE · Q1 FY27 back to Q3 FY25
| ₹ crore | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 74.7 | 74 | 66 | 72.3 | 65.6 | 60.7 | 61.7 |
| Other income | 2.3 | 2.4 | 2.1 | 2.4 | 1.7 | 1.6 | 0.6 |
| Total expenses | 65 | 65.2 | 63.6 | 65.2 | 57.7 | 56.7 | 57.5 |
| EBITDA | 14.4 | 13.5 | 7 | 11 | 11.9 | 9.5 | 9.6 |
| EBITDA margin | 19.2% | 18.3% | 10.5% | 15.3% | 18.2% | 15.7% | 15.6% |
| Finance costs | 0.3 | 0.3 | 0.3 | 0.2 | 0.5 | 1.3 | 1.5 |
| Depreciation | 4.3 | 4.4 | 4.2 | 3.7 | 3.6 | 4.3 | 4 |
| Profit before tax | 12 | 11.1 | −1.2 | 9.4 | 9.6 | 6 | 4.7 |
| Tax | 2.5 | 0.5 | −2.2 | 1.9 | 2.3 | 2.5 | 1.1 |
| Net profit | 10.3 | 10.1 | 2 | 8.5 | 8.3 | 4.3 | 4.8 |
| Net margin | 13.8% | 13.7% | 3.0% | 11.8% | 12.7% | 7.0% | 7.8% |
| EPS (₹) | 1.87 | 1.83 | 0.37 | 1.59 | 1.53 | 0.79 | 0.88 |
| Net profit YoY | +23.8% | +136.1% | −59.3% | – | – | – | – |
Annual results
financial years ending March · from the fourth-quarter filings| ₹ crore | FY26 | FY25 |
|---|---|---|
| Revenue from operations | 278 | 239 |
| Other income | 8.5 | 3.3 |
| Total expenses | 252 | 218 |
| EBITDA | 43.4 | 41.9 |
| EBITDA margin | 15.6% | 17.5% |
| Finance costs | 1.4 | 5.4 |
| Depreciation | 15.9 | 15 |
| Profit before tax | 28.9 | 31.8 |
| Tax | 2.5 | 6.5 |
| Net profit | 28.9 | 31.8 |
| Net margin | 10.4% | 13.3% |
| EPS (₹) | 5.53 | 6.20 |
| Net profit YoY | −9.2% | – |
EPS is as filed for each period and is not restated for later bonus issues or splits.
Cash flow
annual · ₹ crore| ₹ crore | FY26 | FY25 |
|---|---|---|
| Operating cash flow | −5 | 43.8 |
| Investing cash flow | −79.6 | −29.2 |
| Financing cash flow | −17.8 | 111 |
| Capital expenditure | 16.3 | 15.1 |
| Free cash flow (CFO − capex) | −21.3 | 28.7 |
Net profit trend
annual, ₹ croreFY25
₹31.8
FY26
₹28.9−9%
Result filings
as filed with NSE · PDF and XBRL| Period | Basis | Filed | Documents |
|---|---|---|---|
| Q1 FY27 | Consolidated | 11 Aug 2026 | PDF XBRL |
| Q1 FY27 | Standalone | 11 Aug 2026 | PDF XBRL |
| Q4 FY26 | Consolidated · audited | 21 May 2026 | PDF on NSE XBRL |
| Q4 FY26 | Standalone · audited | 21 May 2026 | PDF on NSE XBRL |
| Q3 FY26 | Consolidated | 10 Feb 2026 | PDF on NSE XBRL |
| Q3 FY26 | Standalone | 10 Feb 2026 | PDF on NSE XBRL |
| Q2 FY26 | Consolidated | 18 Dec 2025 | PDF XBRL |
| Q2 FY26 | Standalone | 18 Dec 2025 | PDF XBRL |
| Q1 FY26 | Consolidated | 12 Aug 2025 | PDF XBRL |
| Q1 FY26 | Standalone | 12 Aug 2025 | PDF XBRL |
Annual reports
NSE archiveKey ratios
P/E (TTM)5Y avg 53.5×35.4×
P/B5Y avg 7.70×4.50×
ROEFY26, on average equity12.8%
Net margin10.4%
Debt / equity0.00×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹5.62
Market cap₹1,094 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
4.50×
vs 3-point avg 7.70× (−42%)
3.57× low7.70× avg11.73× high
History points are balance-sheet dates (2025 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹294 Cr+3%
Net worth₹243 Cr+17%
Total borrowings₹0 Cr−100%
Cash & bank balances₹8 Cr−91%
Investments₹13 Cr+22%
Inventories₹22 Cr+17%
Trade receivables₹46 Cr+24%
Trade payables₹11 Cr−67%
Change vs the same date a year earlier.
Revenue mix FY26
Laboratory Business69.8%result ₹30.2 Cr
Aligners Business27.2%result ₹14.4 Cr
Other business3.1%result ₹−1.2 Cr
Segment revenue as reported, before inter-segment eliminations.